持续皮下注射血浆源性C1酯酶抑制剂对凝血和纤溶参数的影响。 - Suppr

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

作者信息

Reshef Avner, Levy Donald, Longhurst Hilary, Cicardi Marco, Craig Timothy, Keith Paul K, Feussner Annette, Feuersenger Henrike, Machnig Thomas, Prusty Subhransu, Pragst Ingo

机构信息

Division of Allergy, Immunology, and Angioedema, Barzilai Medical Center, Ashkelon, Israel.

Division of Basic and Clinical Immunology, Department of Medicine, University of California at Irvine, Orange, California, United States.

出版信息

Thromb Haemost. 2021 May;121(5):690-693. doi: 10.1055/s-0040-1721147. Epub 2020 Nov 17.

DOI:10.1055/s-0040-1721147

PMID:33202446

Abstract

摘要

相似文献

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

Thromb Haemost. 2021 May;121(5):690-693. doi: 10.1055/s-0040-1721147. Epub 2020 Nov 17.

Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.

BioDrugs. 2012 Feb 1;26(1):43-52. doi: 10.2165/11599490-000000000-00000.

Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience.

J Investig Allergol Clin Immunol. 2024 Jun 17;34(3):198-199. doi: 10.18176/jiaci.0948. Epub 2023 Sep 5.

Successful long-term prophylaxis with human plasma-derived C1 inhibitor in planning and carrying out pregnancy.

Allergol Int. 2018 Jan;67(1):144-146. doi: 10.1016/j.alit.2017.05.008. Epub 2017 Jun 16.

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.

Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25.

Haegarda--a subcutaneous C1 esterase inhibitor for prevention of hereditary angioedema.

Med Lett Drugs Ther. 2018 Feb 26;60(1541):39-40.

Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings.

J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):2035-2038. doi: 10.1016/j.jaip.2019.01.007. Epub 2019 Jan 17.

The thrombogenicity of C1 esterase inhibitor (human): review of the evidence.

Allergy Asthma Proc. 2014 Nov-Dec;35(6):444-53. doi: 10.2500/aap.2014.35.3799.

Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema.

CMAJ. 2013 Jun 11;185(9):791-2. doi: 10.1503/cmaj.121364. Epub 2013 Apr 22.

Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue.

Niger J Clin Pract. 2018 Apr;21(4):531-533. doi: 10.4103/njcp.njcp_177_17.

引用本文的文献

Hereditary Angioedema and Venous Thromboembolism: Where There's Smoke, There's Fire.

Semin Thromb Hemost. 2025 Apr;51(3):322-328. doi: 10.1055/s-0044-1791779. Epub 2024 Oct 17.

Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers.

J Allergy Clin Immunol Pract. 2023 Aug;11(8):2286-2301. doi: 10.1016/j.jaip.2023.05.031. Epub 2023 May 30.

Comorbidities in hereditary angioedema-A population-based cohort study.

Clin Transl Allergy. 2022 Mar;12(3):e12135. doi: 10.1002/clt2.12135.

Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.

Clin Rev Allergy Immunol. 2021 Jun;60(3):348-356. doi: 10.1007/s12016-021-08837-6. Epub 2021 May 6.

Biomarkers in Hereditary Angioedema.

Clin Rev Allergy Immunol. 2021 Jun;60(3):404-415. doi: 10.1007/s12016-021-08845-6. Epub 2021 Feb 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

作者信息

Reshef Avner, Levy Donald, Longhurst Hilary, Cicardi Marco, Craig Timothy, Keith Paul K, Feussner Annette, Feuersenger Henrike, Machnig Thomas, Prusty Subhransu, Pragst Ingo

机构信息

Division of Allergy, Immunology, and Angioedema, Barzilai Medical Center, Ashkelon, Israel.

Division of Basic and Clinical Immunology, Department of Medicine, University of California at Irvine, Orange, California, United States.

出版信息

Thromb Haemost. 2021 May;121(5):690-693. doi: 10.1055/s-0040-1721147. Epub 2020 Nov 17.

DOI:10.1055/s-0040-1721147

PMID:33202446

Abstract

摘要

相似文献

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

Thromb Haemost. 2021 May;121(5):690-693. doi: 10.1055/s-0040-1721147. Epub 2020 Nov 17.

Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.

BioDrugs. 2012 Feb 1;26(1):43-52. doi: 10.2165/11599490-000000000-00000.

Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience.

J Investig Allergol Clin Immunol. 2024 Jun 17;34(3):198-199. doi: 10.18176/jiaci.0948. Epub 2023 Sep 5.

Successful long-term prophylaxis with human plasma-derived C1 inhibitor in planning and carrying out pregnancy.

Allergol Int. 2018 Jan;67(1):144-146. doi: 10.1016/j.alit.2017.05.008. Epub 2017 Jun 16.

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.

Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25.

Haegarda--a subcutaneous C1 esterase inhibitor for prevention of hereditary angioedema.

Med Lett Drugs Ther. 2018 Feb 26;60(1541):39-40.

Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings.

J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):2035-2038. doi: 10.1016/j.jaip.2019.01.007. Epub 2019 Jan 17.

The thrombogenicity of C1 esterase inhibitor (human): review of the evidence.

Allergy Asthma Proc. 2014 Nov-Dec;35(6):444-53. doi: 10.2500/aap.2014.35.3799.

Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema.

CMAJ. 2013 Jun 11;185(9):791-2. doi: 10.1503/cmaj.121364. Epub 2013 Apr 22.

Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue.

Niger J Clin Pract. 2018 Apr;21(4):531-533. doi: 10.4103/njcp.njcp_177_17.

引用本文的文献

Hereditary Angioedema and Venous Thromboembolism: Where There's Smoke, There's Fire.

Semin Thromb Hemost. 2025 Apr;51(3):322-328. doi: 10.1055/s-0044-1791779. Epub 2024 Oct 17.

Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers.

J Allergy Clin Immunol Pract. 2023 Aug;11(8):2286-2301. doi: 10.1016/j.jaip.2023.05.031. Epub 2023 May 30.

Comorbidities in hereditary angioedema-A population-based cohort study.

Clin Transl Allergy. 2022 Mar;12(3):e12135. doi: 10.1002/clt2.12135.

Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.

Clin Rev Allergy Immunol. 2021 Jun;60(3):348-356. doi: 10.1007/s12016-021-08837-6. Epub 2021 May 6.

Biomarkers in Hereditary Angioedema.

Clin Rev Allergy Immunol. 2021 Jun;60(3):404-415. doi: 10.1007/s12016-021-08845-6. Epub 2021 Feb 9.

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

作者信息

机构信息

出版信息

相似文献

引用本文的文献